These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2906459)

  • 61. Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy.
    Valis M; Masopust J; Vysata O; Hort J; Dolezal R; Tomek J; Misik J; Kuca K; Karasova JZ
    Neurotox Res; 2017 Jan; 31(1):162-168. PubMed ID: 27718143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease.
    Nakamura K; Akiho H; Ochiai T; Motomura Y; Higuchi N; Okamoto R; Matsui N; Yasuda D; Akahoshi K; Kabemura T; Ihara E; Harada N; Ito T; Takayanagi R
    Hepatogastroenterology; 2010; 57(99-100):497-500. PubMed ID: 20698216
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effects of Cuban analog (SWR-104SA), a new histamine H2 receptor antagonist, on gastric acid secretion and experimental ulcer formation].
    Shinkawa R; Kiso T; Kataoka H; Isoi T; Kakita T; Shogaki T; Ohtsubo Y
    Yakugaku Zasshi; 1996 Oct; 116(10):783-91. PubMed ID: 8950870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.
    Scott-Moncrieff JC; Chan TC; Samuels ML; Cook JR; Coppoc GL; DeNicola DB; Richardson RC
    Cancer Chemother Pharmacol; 1991; 29(1):13-8. PubMed ID: 1742843
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics of a new histamine H2-receptor antagonist, Z-300, in rat and dog.
    Sugimoto T; Furuta S; Kawamata H; Suzuki M; Sano H; Ito T; Hirabayashi N; Imamura F; Matsuki Y
    Xenobiotica; 1999 Apr; 29(4):425-33. PubMed ID: 10375011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates.
    Tanaka E; Nakamura K
    Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Erythema multiforme caused by the H2-blocker, roxatidine.
    Horiuchi Y
    J Dermatol; 2000 May; 27(5):352-3. PubMed ID: 10875206
    [No Abstract]   [Full Text] [Related]  

  • 68. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.
    Judmaier G
    Drugs; 1988; 35 Suppl 3():120-6. PubMed ID: 2905240
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.
    Walt RP; Logan RF; Hawkey CJ; Daneshmend TK; Long RG; Cooper BT; Langman MJ; Collins M; Street R
    Aliment Pharmacol Ther; 1991 Jun; 5(3):301-7. PubMed ID: 1679668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of food-stimulated acid secretion (intragastric titration) by roxatidine acetate. Dose-response study.
    Bonfils S; Chen WW; Vatier J
    Scand J Gastroenterol Suppl; 1988; 146():135-41. PubMed ID: 2906457
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Roxatidine in the treatment of gastroduodenal mucosal lesions in hepatic cirrhosis].
    Sardini C; Ventura P; Abbati GL; Rigo G; Cioni G; Cristani A; Tincani E; Ventura E
    Recenti Prog Med; 1994 Nov; 85(11):517-20. PubMed ID: 7855384
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
    Ikawa K; Shimatani T; Azuma Y; Inoue M; Morikawa N
    J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Roxatidine acetate in the long term maintenance of duodenal ulcers.
    Brunner G
    Drugs; 1988; 35 Suppl 3():102-5. PubMed ID: 2905238
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Radiographic assessment of nocturnal gastric juice secretion after administration of roxatidine acetate hydrochloride.
    Tanioka H; Terahara A; Sasaki Y
    Clin Ther; 1991; 13(1):22-4. PubMed ID: 1674230
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Comparison of the protective effects of roxatidine and misoprostol on diclofenac gastroduodenal pathology. An endoscopic, controlled study of volunteers].
    Müller P; Jackisch P; Simon B
    Arzneimittelforschung; 1994 Oct; 44(10):1127-9. PubMed ID: 7818585
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lichenoid eruptions due to the H2-receptor antagonists roxatidine and ranitidine.
    Horiuchi Y; Katagiri T
    J Dermatol; 1996 Jul; 23(7):510-2. PubMed ID: 8772037
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of histamine H2 receptor antagonists on the secretion of cerebrospinal fluid in the cat.
    Naveh Y; Kitzes R; Lemberger A; Ben-David S; Feinsod M
    J Neurochem; 1992 Apr; 58(4):1347-52. PubMed ID: 1347778
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ketorolac penetration into the cerebrospinal fluid of humans.
    Rice AS; Lloyd J; Bullingham RE; O'Sullivan G
    J Clin Anesth; 1993; 5(6):459-62. PubMed ID: 8123270
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection.
    Burrows JL; Jolley KW; Sullivan DJ
    J Chromatogr; 1988 Nov; 432():199-208. PubMed ID: 2906063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.